Yixuan Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yixuan Shen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adam N. McShane
Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast 1 , Belfast
1 shared publication - Anna E. Kliszczak
Centre for Immuno-Oncology, University of Oxford 2 Nuffield Department of Clinical Medicine Oxford
1 shared publication - Aure Aflalo
Centre for Immuno-Oncology, University of Oxford 2 Nuffield Department of Clinical Medicine Oxford
1 shared publication - Chloe M. Shepherd
School of Life Sciences, University of Dundee, Dundee, Scotland, UK
1 shared publication - Dessislava Malinova
Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast 1 , Belfast
1 shared publication - Fiona Hills
Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast 1 , Belfast
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (9)
SorLA regulates B cell receptor uptake, trafficking, and B cell–mediated immune responses in vivo
A high-affinity antibody response to both infection and vaccination critically relies on the ability of B cells to capture and process antigen for presentation to CD4+ T cells. The cellular processes from antigen recognition to full B cell activation require a finely orchestrated series of events, involving signalling and intracellular trafficking mechanisms. Here, we describe a novel regulator of B cell receptor (BCR) endocytosis and intracellular trafficking. Multidomain trafficking protein sorting-related receptor with A-type repeats (SorLA) associates with the BCR and regulates uptake of both soluble and substrate-bound antigens. SorLA deletion results in altered BCR–antigen intracellular trafficking to degradative compartments, modulating eventual antigen presentation. Crucially, this change in antigen trafficking results in a significant reduction in plasma cells and humoral responses in vivo. Given the critical importance of antigen presentation in immunity, as well as autoimmune disease and malignancy, these results identify a new cellular pathway in B cell biology with potential implications for immune regulation.
- 4 August 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (9)
Open AccessSorLA regulates B cell receptor uptake, trafficking, and B cell–mediated immune responses in vivo
A high-affinity antibody response to both infection and vaccination critically relies on the ability of B cells to capture and process antigen for presentation to CD4+ T cells. The cellular processes from antigen recognition to full B cell activation require a finely orchestrated series of events, involving signalling and intracellular trafficking mechanisms. Here, we describe a novel regulator of B cell receptor (BCR) endocytosis and intracellular trafficking. Multidomain trafficking protein sorting-related receptor with A-type repeats (SorLA) associates with the BCR and regulates uptake of both soluble and substrate-bound antigens. SorLA deletion results in altered BCR–antigen intracellular trafficking to degradative compartments, modulating eventual antigen presentation. Crucially, this change in antigen trafficking results in a significant reduction in plasma cells and humoral responses in vivo. Given the critical importance of antigen presentation in immunity, as well as autoimmune disease and malignancy, these results identify a new cellular pathway in B cell biology with potential implications for immune regulation.